Targeting glutamate uptake to treat alcohol use disorders

Frontiers in Neuroscience

Volumn 9, Issue APR, 2015, Pages

  Rao, P S S ^a,c   Bell, Richard L ^b   Engleman, Eric A ^b   Sari, Youssef ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Alcohol; Dopamine; EAAT2; GLT1; Glutamate; Neurotransmitter

Indexed keywords

1 (3,3 DIMETHYL 1,2 DIOXOPENTYL) 2 PYRROLIDINECARBOXYLIC ACID 3 (3 PYRIDYL)PROPYL ESTER; 5 METHYL 1 NICOTINOYL 2 PYRAZOLINE; ANTIPORTER; CEFTRIAXONE; EXCITATORY AMINO ACID TRANSPORTER; GLUTAMATE TRANSPORTER; GLUTAMIC ACID; IONOTROPIC RECEPTOR; METABOTROPIC RECEPTOR; PYRAZOLINE DERIVATIVE; UNCLASSIFIED DRUG; VESICULAR GLUTAMATE TRANSPORTER;

ALCOHOL CONSUMPTION; ALCOHOL USE DISORDER; ALCOHOLISM; AMYGDALOID NUCLEUS; BRAIN REGION; HOMEOSTASIS; HUMAN; NEUROTRANSMISSION; NONHUMAN; REVIEW;

EID: 84928692251     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2015.00144     Document Type: Review

References (173)

1. Aal-Aaboda, M., Alhaddad, H., Osowik, F., Nauli, S. M., and Sari, Y. (2015). Effects of (R)-(-)-5-methyl-1-nicotinoyl-2-pyrazoline on glutamate transporter 1 and cysteine/glutamate exchanger as well as ethanol drinking behavior in male, alcohol-preferring rats. J. Neurosci. Res. 93, 930-937. doi: 10.1002/jnr.23554
2. Abulseoud, O. A., Camsari, U. M., Ruby, C. L., Kasasbeh, A., Choi, S., and Choi, D. S. (2014). Attenuation of Ethanol withdrawal by ceftriaxone-induced upregulation of glutamate transporter EAAT2. Neuropsychopharmacology 39, 1674-1684. doi: 10.1038/npp.2014.14
3. Alhaddad, H., Das, S. C., and Sari, Y. (2014a). Effects of ceftriaxone on ethanol intake: a possible role for xCT and GLT-1 isoforms modulation of glutamate levels in P rats. Psychopharmacology (Berl). 231, 4049-4057. doi: 10.1007/s00213-014-3545-y
4. Alhaddad, H., Kim, N. T., Aal-Aaboda, M., Althobaiti, Y. S., Leighton, J., Boddu, S. H., et al. (2014b). Effects of MS-153 on chronic ethanol consumption and GLT1 modulation of glutamate levels in male alcohol-preferring rats. Front. Behav. Neurosci. 8:366. doi: 10.3389/fnbeh.2014.00366
5. Anderson, C. M., and Swanson, R. A. (2000). Astrocyte glutamate transport: review of properties, regulation, and physiological functions. Glia 32, 1-14. doi: 10.1002/1098-1136(200010)32:1<1::AID-GLIA10>3.0.CO;2-W
6. Anton, R. F., O'malley, S. S., Ciraulo, D. A., Cisler, R. A., Couper, D., Donovan, D. M., et al. (2006). Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. JAMA 295, 2003-2017. doi: 10.1001/jama.295.17.2003
7. Arriza, J. L., Eliasof, S., Kavanaugh, M. P., and Amara, S. G. (1997). Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc. Natl. Acad. Sci. U.S.A. 94, 4155-4160. doi: 10.1073/pnas.94.8.4155
8. Arriza, J. L., Fairman, W. A., Wadiche, J. I., Murdoch, G. H., Kavanaugh, M. P., and Amara, S. G. (1994). Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14, 5559-5569.
9. Aston-Jones, G., Smith, R. J., Moorman, D. E., and Richardson, K. A. (2009). Role of lateral hypothalamic orexin neurons in reward processing and addiction. Neuropharmacology 56(Suppl. 1), 112-121. doi: 10.1016/j.neuropharm.2008.06.060
10. Babor, T. F., Hofmann, M., Delboca, F. K., Hesselbrock, V., Meyer, R. E., Dolinsky, Z. S., et al. (1992). Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch. Gen. Psychiatry 49, 599-608. doi: 10.1001/archpsyc.1992.01820080007002
11. Baker, D. A., Mcfarland, K., Lake, R. W., Shen, H., Tang, X. C., Toda, S., et al. (2003). Neuroadaptations in cysteine-glutamate exchange underlie cocaine relapse. Nat. Neurosci. 6, 743-749. doi: 10.1038/nn1069
12. Baltieri, D. A., Daro, F. R., Ribeiro, P. L., and De Andrade, A. G. (2008). Comparing topiramate with naltrexone in the treatment of alcohol dependence. Addiction 103, 2035-2044. doi: 10.1111/j.1360-0443.2008.02355.x
13. Barrick, C., and Connors, G. J. (2002). Relapse prevention and maintaining abstinence in older adults with alcohol-use disorders. Drugs Aging 19, 583-594. doi: 10.2165/00002512-200219080-00004
14. Basavarajappa, B. S., Ninan, I., and Arancio, O. (2008). Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. J. Neurochem. 107, 1001-1013. doi: 10.1111/j.1471-4159.2008.05685.x
15. Bass, C. E., Grinevich, V. P., Gioia, D., Day-Brown, J. D., Bonin, K. D., Stuber, G. D., et al. (2013). Optogenetic stimulation of VTA dopamine neurons reveals that tonic but not phasic patterns of dopamine transmission reduce ethanol self-administration. Front. Behav. Neurosci. 7:173. doi: 10.3389/fnbeh.2013.00173
16. Bellocchio, E. E., Hu, H., Pohorille, A., Chan, J., Pickel, V. M., and Edwards, R. H. (1998). The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission. J. Neurosci. 18, 8648-8659.
17. Berton, F., Francesconi, W. G., Madamba, S. G., Zieglgansberger, W., and Siggins, G. R. (1998). Acamprosate enhances N-methyl-D-apartate receptor-mediated neurotransmission but inhibits presynaptic GABA(B) receptors in nucleus accumbens neurons. Alcohol. Clin. Exp. Res. 22, 183-191. doi: 10.1111/j.1530-0277.1998.tb03636.x
18. Besheer, J., Faccidomo, S., Grondin, J. J., and Hodge, C. W. (2008). Regulation of motivation to self-administer ethanol by mGluR5 in alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 32, 209-221. doi: 10.1111/j.1530-0277.2007.00570.x
19. Bienkowski, P., Krzascik, P., Koros, E., Kostowski, W., Scinska, A., and Danysz, W. (2001). Effects of a novel uncompetitive NMDA receptor antagonist, MRZ 2/579 on ethanol self-administration and ethanol withdrawal seizures in the rat. Eur. J. Pharmacol. 413, 81-89. doi: 10.1016/S0014-2999(01)00743-9
20. Bliss, T. V., Collingridge, G. L., and Morris, R. G. (2014). Synaptic plasticity in health and disease: introduction and overview. Philos. Trans. R. Soc. Lond. B Biol. Sci. 369:20130129. doi: 10.1098/rstb.2013.0129
21. Bonci, A., and Borgland, S. (2009). Role of orexin/hypocretin and CRF in the formation of drug-dependent synaptic plasticity in the mesolimbic system. Neuropharmacology 56 (Suppl. 1), 107-111. doi: 10.1016/j.neuropharm.2008.07.024
22. Breslin, F. J., Johnson, B. A., and Lynch, W. J. (2010). Effect of topiramate treatment on ethanol consumption in rats. Psychopharmacology 207, 529-534. doi: 10.1007/s00213-009-1683-4
23. Bridges, R. J., Natale, N. R., and Patel, S. A. (2012). System xc(-) cysteine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS. Br. J. Pharmacol. 165, 20-34. doi: 10.1111/j.1476-5381.2011.01480.x
24. Brooks, A. M., and Berns, G. S. (2013). Aversive stimuli and loss in the mesocorticolimbic dopamine system. Trends Cogn. Sci. 17, 281-286. doi: 10.1016/j.tics.2013.04.001
25. Carlezon, W. A. Jr., and Thomas, M. J. (2009). Biological substrates of reward and aversion: a nucleus accumbens activity hypothesis. Neuropharmacology 56 (Suppl. 1), 122-132. doi: 10.1016/j.neuropharm.2008.06.075
26. Chambers, R. A. (2013). Adult hippocampal neurogenesis in the pathogenesis of addiction and dual diagnosis disorders. Drug Alcohol. Depend. 130, 1-12. doi: 10.1016/j.drugalcdep.2012.12.005
27. Cherpitel, C. J., Moskalewicz, J., and Swiatkiewicz, G. (2004). Drinking patterns and problems in emergency services in Poland. Alcohol Alcohol. 39, 256-261. doi: 10.1093/alcalc/agh053
28. Chiauzzi, E. J. (1991). Preventing Relapse in the Addictions: a Biopsychosocial Approach. New York, NY: Pergamon Press.
29. Cloninger, C. R. (1987). Neurogenetic adaptive mechanisms in alcoholism. Science 236, 410-416. doi: 10.1126/science.2882604
30. Conrod, P. J., Pihl, R. O., Stewart, S. H., and Dongier, M. (2000). Validation of a system of classifying female substance abusers on the basis of personality and motivational risk factors for substance abuse. Psychol. Addict. Behav. 14, 243-256. doi: 10.1037/0893-164X.14.3.243
31. Cotton, N. S. (1979). The familial incidence of alcoholism: a review. J. Stud. Alcohol. 40, 89-116. doi: 10.15288/jsa.1979.40.89
32. Cui, C., Noronha, A., Morikawa, H., Alvarez, V. A., Stuber, G. D., Szumlinski, K. K., et al. (2013). New insights on neurobiological mechanisms underlying alcohol addiction. Neuropharmacology 67, 223-232. doi: 10.1016/j.neuropharm.2012.09.022
33. Dahchour, A., and De Witte, P. (1999). Acamprosate decreases the hypermotility during repeated ethanol withdrawal. Alcohol 18, 77-81. doi: 10.1016/S0741-8329(98)00071-8
34. Dahchour, A., and De Witte, P. (2000). Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate. Prog. Neurobiol. 60, 343-362. doi: 10.1016/S0301-0082(99)00031-3
35. Dahchour, A., De Witte, P., Bolo, N., Nedelec, J. F., Muzet, M., Durbin, P., et al. (1998). Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats. Psychiatry Res. 82, 107-114. doi: 10.1016/S0925-4927(98)00016-X
36. Danbolt, N. C. (2001). Glutamate uptake. Prog. Neurobiol. 65, 1-105. doi: 10.1016/S0301-0082(00)00067-8
37. Danysz, W., Dyr, W., Jankowska, E., Glazewski, S., and Kostowski, W. (1992). The involvement of NMDA receptors in acute and chronic effects of ethanol. Alcohol. Clin. Exp. Res. 16, 499-504. doi: 10.1111/j.1530-0277.1992.tb01407.x
38. Ding, Z. M., Engleman, E. A., Rodd, Z. A., and Mcbride, W. J. (2012). Ethanol increases glutamate neurotransmission in the posterior ventral tegmental area of female wistar rats. Alcohol. Clin. Exp. Res. 36, 633-640. doi: 10.1111/j.1530-0277.2011.01665.x
39. Dundon, W., Lynch, K. G., Pettinati, H. M., and Lipkin, C. (2004). Treatment outcomes in type A and B alcohol dependence 6 months after serotonergic pharmacotherapy. Alcohol. Clin. Exp. Res. 28, 1065-1073. doi: 10.1097/01.ALC.0000130974.50563.04
40. Edwards, R. H. (2007). The neurotransmitter cycle and quantal size. Neuron 55, 835-858. doi: 10.1016/j.neuron.2007.09.001
41. El Mestikawy, S., Wallen-Mackenzie, A., Fortin, G. M., Descarries, L., and Trudeau, L. E. (2011). From glutamate co-release to vesicular synergy: vesicular glutamate transporters. Nat. Rev. Neurosci. 12, 204-216. doi: 10.1038/nrn2969
42. Enoch, M. A., and Goldman, D. (2001). The genetics of alcoholism and alcohol abuse. Curr. Psychiatry Rep. 3, 144-151. doi: 10.1007/s11920-001-0012-3
43. Epstein, E. E., Kahler, C. W., Mccrady, B. S., Lewis, K. D., and Lewis, S. (1995). An empirical classification of drinking patterns among alcoholics: binge, episodic, sporadic, and steady. Addict. Behav. 20, 23-41. doi: 10.1016/0306-4603(94)00043-X
44. Everitt, B. J., and Robbins, T. W. (2013). From the ventral to the dorsal striatum: devolving views of their roles in drug addiction. Neurosci. Biobehav. Rev. 37, 1946-1954. doi: 10.1016/j.neubiorev.2013.02.010
45. Fairman, W. A., Vandenberg, R. J., Arriza, J. L., Kavanaugh, M. P., and Amara, S. G. (1995). An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature 375, 599-603. doi: 10.1038/375599a0
46. Flatscher-Bader, T., and Wilce, P. A. (2008). Impact of alcohol abuse on protein expression of midkine and excitatory amino acid transporter 1 in the human prefrontal cortex. Alcohol. Clin. Exp. Res. 32, 1849-1858. doi: 10.1111/j.1530-0277.2008.00754.x
47. Florez, G., Garcia-Portilla, P., Alvarez, S., Saiz, P. A., Nogueiras, L., and Bobes, J. (2008). Using topiramate or naltrexone for the treatment of alcohol-dependent patients. Alcohol. Clin. Exp. Res. 32, 1251-1259. doi: 10.1111/j.1530-0277.2008.00680.x
48. Fremeau, R. T. Jr., Burman, J., Qureshi, T., Tran, C. H., Proctor, J., Johnson, J., et al. (2002). The identification of vesicular glutamate transporter 3 suggests novel modes of signaling by glutamate. Proc. Natl. Acad. Sci. U.S.A. 99, 14488-14493. doi: 10.1073/pnas.222546799
49. Fremeau, R. T. Jr., Troyer, M. D., Pahner, I., Nygaard, G. O., Tran, C. H., Reimer, R. J., et al. (2001). The expression of vesicular glutamate transporters defines two classes of excitatory synapse. Neuron 31, 247-260. doi: 10.1016/S0896-6273(01)00344-0
50. Fremeau, R. T. Jr., Voglmaier, S., Seal, R. P., and Edwards, R. H. (2004). VGLUTs define subsets of excitatory neurons and suggest novel roles for glutamate. Trends Neurosci. 27, 98-103. doi: 10.1016/j.tins.2003.11.005
51. Ganel, R., Ho, T., Maragakis, N. J., Jackson, M., Steiner, J. P., and Rothstein, J. D. (2006). Selective up-regulation of the glial Na+-dependent glutamate transporter GLT1 by a neuroimmunophilin ligand results in neuroprotection. Neurobiol. Dis. 21, 556-567. doi: 10.1016/j.nbd.2005.08.014
52. Gegelashvili, G., and Schousboe, A. (1998). Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res. Bull. 45, 233-238. doi: 10.1016/S0361-9230(97)00417-6
53. Grant, J., Potenza, M., Hollander, E., Kim, S. W., and Cunningham-Williams, R. (2004). A multicenter investigation of fixed-dose nalmefene in the treatment of pathological gambling. Neuropsychopharmacology 29, S122-S122.
54. Gremel, C. M., Gabriel, K. I., and Cunningham, C. L. (2006). Topiramate does not affect the acquisition or expression of ethanol conditioned place preference in DBA/2J or C57BL/6J mice. Alcohol. Clin. Exp. Res. 30, 783-790. doi: 10.1111/j.1530-0277.2006.00091.x
55. Gryder, D. S., and Rogawski, M. A. (2003). Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons. J. Neurosci. 23, 7069-7074.
56. Hargreaves, G. A., and Mcgregor, I. S. (2007). Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats. Alcohol. Clin. Exp. Res. 31, 1900-1907. doi: 10.1111/j.1530-0277.2007.00485.x
57. Harwood, H. J., Fountain, D., and Fountain, G. (1999). Economic cost of alcohol and drug abuse in the United States, 1992: a report. Addiction 94, 631-635.
58. Haydon, P. G., Blendy, J., Moss, S. J., and Rob Jackson, F. (2009). Astrocytic control of synaptic transmission and plasticity: a target for drugs of abuse? Neuropharmacology 56 (Suppl. 1), 83-90. doi: 10.1016/j.neuropharm.2008.06.050
59. Heather, N., Tebbutt, J. S., Mattick, R. P., and Zamir, R. (1993). Development of a scale for measuring impaired control over alcohol consumption: a preliminary report. J. Stud. Alcohol. 54, 700-709. doi: 10.15288/jsa.1993.54.700
60. Heilig, M., and Egli, M. (2006). Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms. Pharmacol. Ther. 111, 855-876. doi: 10.1016/j.pharmthera.2006.02.001
61. Herzog, E., Takamori, S., Jahn, R., Brose, N., and Wojcik, S. M. (2006). Synaptic and vesicular co-localization of the glutamate transporters VGLUT1 and VGLUT2 in the mouse hippocampus. J. Neurochem. 99, 1011-1018. doi: 10.1111/j.1471-4159.2006.04144.x
62. Hoffman, P. L., Rabe, C. S., Moses, F., and Tabakoff, B. (1989). N-methyl-D-aspartate receptors and ethanol: inhibition of calcium flux and cyclic GMP production. J. Neurochem. 52, 1937-1940. doi: 10.1111/j.1471-4159.1989.tb07280.x
63. Holmes, A., Spanagel, R., and Krystal, J. H. (2013). Glutamatergic targets for new alcohol medications. Psychopharmacology (Berl) 229, 539-554. doi: 10.1007/s00213-013-3226-2
64. Howland, R. H. (2013). Gabapentin for the treatment of substance use disorders. J. Psychosoc. Nurs. Ment. Health Serv. 51, 11-14. doi: 10.3928/02793695-20131120-01
65. Jaffe, S. L. (2002). Treatment and relapse prevention for adolescent substance abuse. Pediatr. Clin. North Am. 49, 345-352, vi. doi: 10.1016/S0031-3955(01)00008-6
66. Jennings, J. H., Sparta, D. R., Stamatakis, A. M., Ung, R. L., Pleil, K. E., Kash, T. L., et al. (2013). Distinct extended amygdala circuits for divergent motivational states. Nature 496, 224-228. doi: 10.1038/nature12041
67. Johnson, B. A. (2004). Role of the serotonergic system in the neurobiology of alcoholism: implications for treatment. CNS Drugs 18, 1105-1118. doi: 10.2165/00023210-200418150-00005
68. Johnson, B. A. (2010). Medication treatment of different types of alcoholism. Am. J. Psychiatry 167, 630-639. doi: 10.1176/appi.ajp.2010.08101500
69. Johnson, B. A., Ait-Daoud, N., Ma, J. Z., and Wang, Y. (2003). Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals. Alcohol. Clin. Exp. Res. 27, 1773-1779. doi: 10.1097/01.ALC.0000095635.46911.5D
70. Jupp, B., and Lawrence, A. J. (2010). New horizons for therapeutics in drug and alcohol abuse. Pharmacol. Ther. 125, 138-168. doi: 10.1016/j.pharmthera.2009.11.002
71. Kalivas, P. W., Lalumiere, R. T., Knackstedt, L., and Shen, H. (2009). Glutamate transmission in addiction. Neuropharmacology 56 (Suppl. 1), 169-173. doi: 10.1016/j.neuropharm.2008.07.011
72. Kanai, Y., Bhide, P. G., Difiglia, M., and Hediger, M. A. (1995). Neuronal high-affinity glutamate transport in the rat central nervous system. Neuroreport 6, 2357-2362. doi: 10.1097/00001756-199511270-00020
73. Kanai, Y., and Hediger, M. A. (1992). Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360, 467-471. doi: 10.1038/360467a0
74. Kaneko, T., and Fujiyama, F. (2002). Complementary distribution of vesicular glutamate transporters in the central nervous system. Neurosci. Res. 42, 243-250. doi: 10.1016/S0168-0102(02)00009-3
75. Kapasova, Z., and Szumlinski, K. K. (2008). Strain differences in alcohol-induced neurochemical plasticity: a role for accumbens glutamate in alcohol intake. Alcohol. Clin. Exp. Res. 32, 617-631. doi: 10.1111/j.1530-0277.2008.00620.x
76. Kash, T. L. (2012). The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse. Alcohol 46, 303-308. doi: 10.1016/j.alcohol.2011.12.004
77. Kenny, P. J. (2011). Reward mechanisms in obesity: new insights and future directions. Neuron 69, 664-679. doi: 10.1016/j.neuron.2011.02.016
78. Knackstedt, L. A., Melendez, R. I., and Kalivas, P. W. (2010). Ceftriaxone restores glutamate homeostasis and prevents relapse to cocaine seeking. Biol. Psychiatry 67, 81-84. doi: 10.1016/j.biopsych.2009.07.018
79. Koob, G. F. (2009). Dynamics of neuronal circuits in addiction: reward, antireward, and emotional memory. Pharmacopsychiatry 42 (Suppl. 1), S32-S41. doi: 10.1055/s-0029-1216356
80. Koob, G. F. (2013). Negative reinforcement in drug addiction: the darkness within. Curr. Opin. Neurobiol. 23, 559-563. doi: 10.1016/j.conb.2013.03.011
81. Koob, G. F., and Le Moal, M. (2008). Neurobiological mechanisms for opponent motivational processes in addiction. Philos. Trans. R. Soc. Lond. B Biol. Sci. 363, 3113-3123. doi: 10.1098/rstb.2008.0094
82. Koob, G. F., and Volkow, N. D. (2010). Neurocircuitry of addiction. Neuropsychopharmacology 35, 217-238. doi: 10.1038/npp.2009.110
83. Kryger, R., and Wilce, P. A. (2010). The effects of alcoholism on the human basolateral amygdala. Neuroscience 167, 361-371. doi: 10.1016/j.neuroscience.2010.01.061
84. Lancaster, F. E. (1994). Gender differences in the brain: implications for the study of human alcoholism. Alcohol. Clin. Exp. Res. 18, 740-746. doi: 10.1111/j.1530-0277.1994.tb00940.x
85. Leriche, M., Mendez, M., Zimmer, L., and Berod, A. (2008). Acute ethanol induces Fos in GABAergic and non-GABAergic forebrain neurons: a double-labeling study in the medial prefrontal cortex and extended amygdala. Neuroscience 153, 259-267. doi: 10.1016/j.neuroscience.2008.01.069
86. Lesch, O. M., and Walter, H. (1996). Subtypes of alcoholism and their role in therapy. Alcohol Alcohol. Suppl. 31, 63-67. doi: 10.1093/oxfordjournals.alcalc.a008221
87. Li, J., Cheng, Y., Bian, W., Liu, X., Zhang, C., and Ye, J. H. (2010). Region-specific induction of FosB/DeltaFosB by voluntary alcohol intake: effects of naltrexone. Alcohol. Clin. Exp. Res. 34, 1742-1750. doi: 10.1111/j.1530-0277.2010.01261.x
88. Li, Y., Sattler, R., Yang, E. J., Nunes, A., Ayukawa, Y., Akhtar, S., et al. (2011). Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression. Neuropharmacology 60, 1168-1175. doi: 10.1016/j.neuropharm.2010.10.016
89. Luscher, C., and Malenka, R. C. (2011). Drug-evoked synaptic plasticity in addiction: from molecular changes to circuit remodeling. Neuron 69, 650-663. doi: 10.1016/j.neuron.2011.01.017
90. Malinowska, B., Napiorkowska-Pawlak, D., Pawlak, R., Buczko, W., and Gothert, M. (1999). Ifenprodil influences changes in mouse behaviour related to acute and chronic ethanol administration. Eur. J. Pharmacol. 377, 13-19. doi: 10.1016/S0014-2999(99)00393-3
91. Maragakis, N. J., and Rothstein, J. D. (2006). Mechanisms of Disease: astrocytes in neurodegenerative disease. Nat. Clin. Pract. Neurol. 2, 679-689. doi: 10.1038/ncpneuro0355
92. Mason, B. J., Goodman, A. M., Chabac, S., and Lehert, P. (2006). Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation. J. Psychiatr. Res. 40, 383-393. doi: 10.1016/j.jpsychires.2006.02.002
93. Mason, B. J., and Lehert, P. (2012). Acamprosate for alcohol dependence: a sex-specific meta-analysis based on individual patient data. Alcohol. Clin. Exp. Res. 36, 497-508. doi: 10.1111/j.1530-0277.2011.01616.x
94. Meinhardt, M. W., Hansson, A. C., Perreau-Lenz, S., Bauder-Wenz, C., Stahlin, O., Heilig, M., et al. (2013). Rescue of infralimbic mGluR2 deficit restores control over drug-seeking behavior in alcohol dependence. J. Neurosci. 33, 2794-2806. doi: 10.1523/JNEUROSCI.4062-12.2013
95. Melendez, R. I., Hicks, M. P., Cagle, S. S., and Kalivas, P. W. (2005). Ethanol exposure decreases glutamate uptake in the nucleus accumbens. Alcohol. Clin. Exp. Res. 29, 326-333. doi: 10.1097/01.ALC.0000156086.65665.4D
96. Mokdad, A. H., Marks, J. S., Stroup, D. F., and Gerberding, J. L. (2004). Actual causes of death in the United States, 2000. JAMA 291, 1238-1245. doi: 10.1001/jama.291.10.1238
97. Murphy, T. H., Miyamoto, M., Sastre, A., Schnaar, R. L., and Coyle, J. T. (1989). Glutamate toxicity in a neuronal cell line involves inhibition of cysteine transport leading to oxidative stress. Neuron 2, 1547-1558. doi: 10.1016/0896-6273(89)90043-3
98. Nakanishi, S. (1992). Molecular diversity of glutamate receptors and implications for brain function. Science 258, 597-603. doi: 10.1126/science.1329206
99. Nam, H. W., Mciver, S. R., Hinton, D. J., Thakkar, M. M., Sari, Y., Parkinson, F. E., et al. (2012). Adenosine and glutamate signaling in neuron-glial interactions: implications in alcoholism and sleep disorders. Alcohol. Clin. Exp. Res. 36, 1117-1125. doi: 10.1111/j.1530-0277.2011.01722.x
100. Narita, M., Soma, M., Mizoguchi, H., Tseng, L. F., and Suzuki, T. (2000). Implications of the NR2B subunit-containing NMDA receptor localized in mouse limbic forebrain in ethanol dependence. Eur. J. Pharmacol. 401, 191-195. doi: 10.1016/S0014-2999(00)00428-3
101. Nelson, T. E., Ur, C. L., and Gruol, D. L. (2005). Chronic intermittent ethanol exposure enhances NMDA-receptor-mediated synaptic responses and NMDA receptor expression in hippocampal CA1 region. Brain Res. 1048, 69-79. doi: 10.1016/j.brainres.2005.04.041
102. Nguyen, S. A., Malcolm, R., and Middaugh, L. D. (2007). Topiramate reduces ethanol consumption by C57BL/6 mice. Synapse 61, 150-156. doi: 10.1002/syn.20350
103. Nie, Z., Madamba, S. G., and Siggins, G. R. (1994). Ethanol inhibits glutamatergic neurotransmission in nucleus accumbens neurons by multiple mechanisms. J. Pharmacol. Exp. Ther. 271, 1566-1573.
104. Obara, I., Bell, R. L., Goulding, S. P., Reyes, C. M., Larson, L. A., Ary, A. W., et al. (2009). Differential effects of chronic ethanol consumption and withdrawal on homer/glutamate receptor expression in subregions of the accumbens and amygdala of P rats. Alcohol. Clin. Exp. Res. 33, 1924-1934. doi: 10.1111/j.1530-0277.2009.01030.x
105. O'dell, L. E. (2009). A psychobiological framework of the substrates that mediate nicotine use during adolescence. Neuropharmacology 56 (Suppl. 1), 263-278. doi: 10.1016/j.neuropharm.2008.07.039
106. Pani, P. P., Trogu, E., Pacini, M., and Maremmani, I. (2014). Anticonvulsants for alcohol dependence. Cochrane Database Syst. Rev. 2:CD008544. doi: 10.1002/14651858.CD008544.pub2
107. Pin, J. P., and Duvoisin, R. (1995). The metabotropic glutamate receptors: structure and functions. Neuropharmacology 34, 1-26. doi: 10.1016/0028-3908(94)00129-G
108. Pines, G., Danbolt, N. C., Bjoras, M., Zhang, Y., Bendahan, A., Eide, L., et al. (1992). Cloning and expression of a rat brain L-glutamate transporter. Nature 360, 464-467. doi: 10.1038/360464a0
109. Potenza, M. N., Sofuoglu, M., Carroll, K. M., and Rounsaville, B. J. (2011). Neuroscience of behavioral and pharmacological treatments for addictions. Neuron 69, 695-712. doi: 10.1016/j.neuron.2011.02.009
110. Qrunfleh, A. M., Alazizi, A., and Sari, Y. (2013). Ceftriaxone, a beta-lactam antibiotic, attenuates relapse-like ethanol-drinking behavior in alcohol-preferring rats. J. Psychopharmacol. 27, 541-549. doi: 10.1177/0269881113482529
111. Ramos, K. M., Lewis, M. T., Morgan, K. N., Crysdale, N. Y., Kroll, J. L., Taylor, F. R., et al. (2010). Spinal upregulation of glutamate transporter GLT-1 by ceftriaxone: therapeutic efficacy in a range of experimental nervous system disorders. Neuroscience 169, 1888-1900. doi: 10.1016/j.neuroscience.2010.06.014
112. Rao, P., and Sari, Y. (2014a). Effectiveness of ceftriaxone treatment in preventing relapse-like drinking behavior following long-term Ethanol dependence in P Rats. J. Addict. Res. Ther. 5:1000183. doi: 10.4172/2155-6105.1000183
113. Rao, P. S., and Sari, Y. (2012). Glutamate transporter 1: target for the treatment of alcohol dependence. Curr. Med. Chem. 19, 5148-5156. doi: 10.2174/092986712803530511
114. Rao, P. S., and Sari, Y. (2014b). Effects of ceftriaxone on chronic Ethanol consumption: a potential role for xCT and GLT1 modulation of glutamate levels in Male P Rats. J. Mol. Neurosci. 54, 71-77. doi: 10.1007/s12031-014-0251-5
115. Rao, P. S., Saternos, H., Goodwani, S., and Sari, Y. (2015). Effects of ceftriaxone on GLT1 isoforms, xCT and associated signaling pathways in P rats exposed to ethanol. Psychopharmacology (Berl). doi: 10.1007/s00213-015-3868-3. [Epub ahead of print].
116. Reed, T., Page, W. F., Viken, R. J., and Christian, J. C. (1996). Genetic predisposition to organ-specific endpoints of alcoholism. Alcohol. Clin. Exp. Res. 20, 1528-1533. doi: 10.1111/j.1530-0277.1996.tb01695.x
117. Rehm, J., Room, R., Graham, K., Monteiro, M., Gmel, G., and Sempos, C. T. (2003). The relationship of average volume of alcohol consumption and patterns of drinking to burden of disease: an overview. Addiction 98, 1209-1228. doi: 10.1046/j.1360-0443.2003.00467.x
118. Renthal, W., and Nestler, E. J. (2009). Histone acetylation in drug addiction. Semin. Cell. Dev. Biol. 20, 387-394. doi: 10.1016/j.semcdb.2009.01.005
119. Richard, J. M., Castro, D. C., Difeliceantonio, A. G., Robinson, M. J., and Berridge, K. C. (2013). Mapping brain circuits of reward and motivation: in the footsteps of Ann Kelley. Neurosci. Biobehav. Rev. 37, 1919-1931. doi: 10.1016/j.neubiorev.2012.12.008
120. Richards, D. M., Heel, R. C., Brogden, R. N., Speight, T. M., and Avery, G. S. (1984). Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 27, 469-527. doi: 10.2165/00003495-198427060-00001
121. Roberto, M., Gilpin, N. W., and Siggins, G. R. (2012). The central amygdala and alcohol: role of gamma-aminobutyric acid, glutamate, and neuropeptides. Cold Spring Harb. Perspect. Med. 2:a012195. doi: 10.1101/cshperspect.a012195
122. Roberto, M., Madamba, S. G., Moore, S. D., Tallent, M. K., and Siggins, G. R. (2003). Ethanol increases GABAergic transmission at both pre- and postsynaptic sites in rat central amygdala neurons. Proc. Natl. Acad. Sci. U.S.A. 100, 2053-2058. doi: 10.1073/pnas.0437926100
123. Roberto, M., Schweitzer, P., Madamba, S. G., Stouffer, D. G., Parsons, L. H., and Siggins, G. R. (2004). Acute and chronic ethanol alter glutamatergic transmission in rat central amygdala: an in vitro and in vivo analysis. J. Neurosci. 24, 1594-1603. doi: 10.1523/JNEUROSCI.5077-03.2004
124. Robinson, T. E., and Berridge, K. C. (2008). Review. The incentive sensitization theory of addiction: some current issues. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 363, 3137-3146. doi: 10.1098/rstb.2008.0093
125. Root, D. H., Mejias-Aponte, C. A., Qi, J., and Morales, M. (2014). Role of glutamatergic projections from ventral tegmental area to lateral habenula in aversive conditioning. J. Neurosci. 34, 13906-13910. doi: 10.1523/JNEUROSCI.2029-14.2014
126. Rossetti, Z. L., and Carboni, S. (1995). Ethanol withdrawal is associated with increased extracellular glutamate in the rat striatum. Eur. J. Pharmacol. 283, 177-183. doi: 10.1016/0014-2999(95)00344-K
127. Rothstein, J. D., Patel, S., Regan, M. R., Haenggeli, C., Huang, Y. H., Bergles, D. E., et al. (2005). Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression. Nature 433, 73-77. doi: 10.1038/nature03180
128. Russo, S. J., Mazei-Robison, M. S., Ables, J. L., and Nestler, E. J. (2009). Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56 (Suppl. 1), 73-82. doi: 10.1016/j.neuropharm.2008.06.059
129. Sari, Y., Sakai, M., Weedman, J. M., Rebec, G. V., and Bell, R. L. (2011). Ceftriaxone, a beta-lactam antibiotic, reduces ethanol consumption in alcohol-preferring rats. Alcohol Alcohol. 46, 239-246. doi: 10.1093/alcalc/agr023
130. Sari, Y., Smith, K. D., Ali, P. K., and Rebec, G. V. (2009). Upregulation of GLT1 attenuates cue-induced reinstatement of cocaine-seeking behavior in rats. J. Neurosci. 29, 9239-9243. doi: 10.1523/JNEUROSCI.1746-09.2009
131. Sari, Y., and Sreemantula, S. N. (2012). Neuroimmunophilin GPI-1046 reduces ethanol consumption in part through activation of GLT1 in alcohol-preferring rats. Neuroscience 227, 327-335. doi: 10.1016/j.neuroscience.2012.10.007
132. Sari, Y., Sreemantula, S. N., Lee, M. R., and Choi, D. S. (2013). Ceftriaxone treatment affects the levels of GLT1 and ENT1 as well as Ethanol Intake in Alcohol-Preferring Rats. J. Mol. Neurosci. 51, 779-787. doi: 10.1007/s12031-013-0064-y
133. Sato, H., Tamba, M., Ishii, T., and Bannai, S. (1999). Cloning and expression of a plasma membrane cysteine/glutamate exchange transporter composed of two distinct proteins. J. Biol. Chem. 274, 11455-11458. doi: 10.1074/jbc.274.17.11455
134. Sattler, R., and Tymianski, M. (2001). Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 24, 107-129. doi: 10.1385/MN:24:1-3:107
135. Schroeder, J. P., Overstreet, D. H., and Hodge, C. W. (2005). The mGluR5 antagonist MPEP decreases operant ethanol self-administration during maintenance and after repeated alcohol deprivations in alcohol-preferring (P) rats. Psychopharmacology (Berl) 179, 262-270. doi: 10.1007/s00213-005-2175-9
136. Seal, R. P., and Amara, S. G. (1999). Excitatory amino acid transporters: a family in flux. Annu. Rev. Pharmacol. Toxicol. 39, 431-456. doi: 10.1146/annurev.pharmtox.39.1.431
137. Seal, R. P., and Edwards, R. H. (2006). The diverse roles of vesicular glutamate transporter 3. Handb. Exp. Pharmacol. 137-150. doi: 10.1007/3-540-29784-7_7
138. Shield, K. D., Rylett, M., Gmel, G., Kehoe-Chan, T. A., and Rehm, J. (2013). Global alcohol exposure estimates by country, territory and region for 2005-a contribution to the Comparative Risk Assessment for the 2010 Global Burden of Disease Study. Addiction 108, 912-922. doi: 10.1111/add.12112
139. Skradski, S., and White, H. S. (2000). Topiramate blocks kainate-evoked cobalt influx into cultured neurons. Epilepsia 41, S45-S47. doi: 10.1111/j.1528-1157.2000.tb02171.x
140. Snell, L. D., Nunley, K. R., Lickteig, R. L., Browning, M. D., Tabakoff, B., and Hoffman, P. L. (1996). Regional and subunit specific changes in NMDA receptor mRNA and immunoreactivity in mouse brain following chronic ethanol ingestion. Brain Res. Mol. Brain Res. 40, 71-78. doi: 10.1016/0169-328X(96)00038-1
141. Spanagel, R. (2009). Alcoholism: a systems approach from molecular physiology to addictive behavior. Physiol. Rev. 89, 649-705. doi: 10.1152/physrev.00013.2008
142. Stamatakis, A. M., Jennings, J. H., Ung, R. L., Blair, G. A., Weinberg, R. J., Neve, R. L., et al. (2013). A unique population of ventral tegmental area neurons inhibits the lateral habenula to promote reward. Neuron 80, 1039-1053. doi: 10.1016/j.neuron.2013.08.023
143. Steiner, J. P., Connolly, M. A., Valentine, H. L., Hamilton, G. S., Dawson, T. M., Hester, L., et al. (1997a). Neurotrophic actions of nonimmunosuppressive analogues of immunosuppressive drugs FK506, rapamycin and cyclosporin A. Nat. Med. 3, 421-428. doi: 10.1038/nm0497-421
144. Steiner, J. P., Galey, D., Haughey, N. J., Asch, D., and Nath, A. (2007). Neuroprotective and antiretroviral effects of the immunophilin ligand GPI 1046. J. Neuroimmune. Pharmacol. 2, 49-57. doi: 10.1007/s11481-006-9060-0
145. Steiner, J. P., Hamilton, G. S., Ross, D. T., Valentine, H. L., Guo, H., Connolly, M. A., et al. (1997b). Neurotrophic immunophilin ligands stimulate structural and functional recovery in neurodegenerative animal models. Proc. Natl. Acad. Sci. U.S.A. 94, 2019-2024. doi: 10.1073/pnas.94.5.2019
146. Stobbs, S. H., Ohran, A. J., Lassen, M. B., Allison, D. W., Brown, J. E., and Steffensen, S. C. (2004). Ethanol suppression of ventral tegmental area GABA neuron electrical transmission involves N-methyl-D-aspartate receptors. J. Pharmacol. Exp. Ther. 311, 282-289. doi: 10.1124/jpet.104.071860
147. Storck, T., Schulte, S., Hofmann, K., and Stoffel, W. (1992). Structure, expression, and functional analysis of a Na(+)-dependent glutamate/aspartate transporter from rat brain. Proc. Natl. Acad. Sci. U.S.A. 89, 10955-10959. doi: 10.1073/pnas.89.22.10955
148. Sulzer, D. (2011). How addictive drugs disrupt presynaptic dopamine neurotransmission. Neuron 69, 628-649. doi: 10.1016/j.neuron.2011.02.010
149. Suvarna, N., Borgland, S. L., Wang, J., Phamluong, K., Auberson, Y. P., Bonci, A., et al. (2005). Ethanol alters trafficking and functional N-methyl-D-aspartate receptor NR2 subunit ratio via H-Ras. J. Biol. Chem. 280, 31450-31459. doi: 10.1074/jbc. M504120200
150. Tabakoff, B., and Hoffman, P. L. (2013). The neurobiology of alcohol consumption and alcoholism: an integrative history. Pharmacol. Biochem. Behav. 113, 20-37. doi: 10.1016/j.pbb.2013.10.009
151. Taylor, J. R., Olausson, P., Quinn, J. J., and Torregrossa, M. M. (2009). Targeting extinction and reconsolidation mechanisms to combat the impact of drug cues on addiction. Neuropharmacology 56 (Suppl. 1), 186-195. doi: 10.1016/j.neuropharm.2008.07.027
152. Thone-Reineke, C., Neumann, C., Namsolleck, P., Schmerbach, K., Krikov, M., Schefe, J. H., et al. (2008). The beta-lactam antibiotic, ceftriaxone, dramatically improves survival, increases glutamate uptake and induces neurotrophins in stroke. J. Hypertens. 26, 2426-2435. doi: 10.1097/HJH.0b013e328313e403
153. Tzschentke, T. M. (2000). The medial prefrontal cortex as a part of the brain reward system. Amino Acids 19, 211-219. doi: 10.1007/s007260070051
154. Valenzuela, C. F. (1997). Alcohol and neurotransmitter interactions. Alcohol Health Res. World 21, 144-148.
155. Vezina, P., and Leyton, M. (2009). Conditioned cues and the expression of stimulant sensitization in animals and humans. Neuropharmacology 56 (Suppl. 1), 160-168. doi: 10.1016/j.neuropharm.2008.06.070
156. Volkow, N. D., and Baler, R. D. (2013). Brain imaging biomarkers to predict relapse in alcohol addiction. JAMA Psychiatry 70, 661-663. doi: 10.1001/jamapsychiatry.2013.1141
157. Volkow, N. D., Fowler, J. S., Wang, G. J., Baler, R., and Telang, F. (2009). Imaging dopamine's role in drug abuse and addiction. Neuropharmacology 56 (Suppl. 1), 3-8. doi: 10.1016/j.neuropharm.2008.05.022
158. Volkow, N. D., and Li, T. K. (2005). Drugs and alcohol: treating and preventing abuse, addiction and their medical consequences. Pharmacol. Ther. 108, 3-17. doi: 10.1016/j.pharmthera.2005.06.021
159. Volkow, N. D., Wang, G. J., Fowler, J. S., Tomasi, D., Telang, F., and Baler, R. (2010). Addiction: decreased reward sensitivity and increased expectation sensitivity conspire to overwhelm the brain's control circuit. Bioessays 32, 748-755. doi: 10.1002/bies.201000042
160. Volman, S. F., Lammel, S., Margolis, E. B., Kim, Y., Richard, J. M., Roitman, M. F., et al. (2013). New insights into the specificity and plasticity of reward and aversion encoding in the mesolimbic system. J. Neurosci. 33, 17569-17576. doi: 10.1523/JNEUROSCI.3250-13.2013
161. Wang, Y., and Qin, Z. H. (2010). Molecular and cellular mechanisms of excitotoxic neuronal death. Apoptosis 15, 1382-1402. doi: 10.1007/s10495-010-0481-0
162. Weiss, F., Ciccocioppo, R., Parsons, L. H., Katner, S., Liu, X., Zorrilla, E. P., et al. (2001). Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. N.Y. Acad. Sci. 937, 1-26. doi: 10.1111/j.1749-6632.2001.tb03556.x
163. Wheeler, R. A., and Carelli, R. M. (2009). Dissecting motivational circuitry to understand substance abuse. Neuropharmacology 56 (Suppl. 1), 149-159. doi: 10.1016/j.neuropharm.2008.06.028
164. White, N. M. (1996). Addictive drugs as reinforcers: multiple partial actions on memory systems. Addiction 91, 921-949; discussion 951-965. doi: 10.1046/j.1360-0443.1996.9179212.x
165. Wirkner, K., Eberts, C., Poelchen, W., Allgaier, C., and Illes, P. (2000). Mechanism of inhibition by ethanol of NMDA and AMPA receptor channel functions in cultured rat cortical neurons. Naunyn Schmiedebergs Arch. Pharmacol. 362, 568-576. doi: 10.1007/s002100000262
166. Wise, R. A. (2005). Forebrain substrates of reward and motivation. J. Comp. Neurol. 493, 115-121. doi: 10.1002/cne.20689
167. Wise, R. A., and Koob, G. F. (2014). The development and maintenance of drug addiction. Neuropsychopharmacology 39, 254-262. doi: 10.1038/npp.2013.261
168. Zerangue, N., and Kavanaugh, M. P. (1996). Flux coupling in a neuronal glutamate transporter. Nature 383, 634-637. doi: 10.1038/383634a0
169. Zhou, F. C., Sahr, R. N., Sari, Y., and Behbahani, K. (2006). Glutamate and dopamine synaptic terminals in extended amygdala after 14-week chronic alcohol drinking in inbred alcohol-preferring rats. Alcohol 39, 39-49. doi: 10.1016/j.alcohol.2006.06.013
170. Zhou, Z., Karlsson, C., Liang, T., Xiong, W., Kimura, M., Tapocik, J. D., et al. (2013). Loss of metabotropic glutamate receptor 2 escalates alcohol consumption. Proc. Natl. Acad. Sci. U.S.A. 110, 16963-16968. doi: 10.1073/pnas.1309839110
171. Zhu, W., Bie, B., and Pan, Z. Z. (2007). Involvement of non-NMDA glutamate receptors in central amygdala in synaptic actions of ethanol and ethanol-induced reward behavior. J. Neurosci. 27, 289-298. doi: 10.1523/JNEUROSCI.3912-06.2007
172. Zorrilla, E. P., and Koob, G. F. (2013). Amygdalostriatal projections in the neurocircuitry for motivation: a neuroanatomical thread through the career of Ann Kelley. Neurosci. Biobehav. Rev. 37, 1932-1945. doi: 10.1016/j.neubiorev.2012.11.019
173. Zucker, R. A. (1995). "Pathways to alcohol problems and alcoholism: a developmental account of the evidence for multiple alcoholisms and for contextual contributions to risk," in The Development of Alcohol Problems: Exploring the Biopsychosocial Matrix of Risk, eds R. A. Zucker, G. M. Boyd, J. Howard (Rockville, MD: NIAAA Research Monograph 26;U.S. Department of Health and Human Services;National Institute on Alcohol Abuse and Alcoholism), 255-289.